179 related articles for article (PubMed ID: 27855370)
21. Hypomethylation-induced expression of S100A4 increases the invasiveness of laryngeal squamous cell carcinoma.
Liu J; Guo Y; Fu S; Yang M; Sun KL; Fu WN
Oncol Rep; 2010 Apr; 23(4):1101-7. PubMed ID: 20204297
[TBL] [Abstract][Full Text] [Related]
22. Anti-SIRP
Yanagita T; Murata Y; Tanaka D; Motegi SI; Arai E; Daniwijaya EW; Hazama D; Washio K; Saito Y; Kotani T; Ohnishi H; Oldenborg PA; Garcia NV; Miyasaka M; Ishikawa O; Kanai Y; Komori T; Matozaki T
JCI Insight; 2017 Jan; 2(1):e89140. PubMed ID: 28097229
[TBL] [Abstract][Full Text] [Related]
23. Notch 2 signaling contributes to cell growth, anti-apoptosis and metastasis in laryngeal squamous cell carcinoma.
Zou Y; Fang F; Ding YJ; Dai MY; Yi X; Chen C; Tao ZZ; Chen SM
Mol Med Rep; 2016 Oct; 14(4):3517-24. PubMed ID: 27572051
[TBL] [Abstract][Full Text] [Related]
24. miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC).
Yungang W; Xiaoyu L; Pang T; Wenming L; Pan X
Biomed Pharmacother; 2014 Mar; 68(2):149-54. PubMed ID: 24055400
[TBL] [Abstract][Full Text] [Related]
25. A homogeneous SIRPα-CD47 cell-based, ligand-binding assay: Utility for small molecule drug development in immuno-oncology.
Burgess TL; Amason JD; Rubin JS; Duveau DY; Lamy L; Roberts DD; Farrell CL; Inglese J; Thomas CJ; Miller TW
PLoS One; 2020; 15(4):e0226661. PubMed ID: 32240171
[TBL] [Abstract][Full Text] [Related]
26. Binding Mechanism of CD47 with SIRPα Variants and Its Antibody: Elucidated by Molecular Dynamics Simulations.
Huang K; Liu Y; Wen S; Zhao Y; Ding H; Liu H; Kong DX
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375166
[TBL] [Abstract][Full Text] [Related]
27. The Long Noncoding RNA TUG1 Promotes Laryngeal Cancer Proliferation and Migration.
Zhang Z; Wang X; Cao S; Han X; Wang Z; Zhao X; Liu X; Li G; Pan X; Lei D
Cell Physiol Biochem; 2018; 49(6):2511-2520. PubMed ID: 30261503
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of miR-129-5p affects laryngeal cancer cell proliferation, invasiveness, and migration by affecting STAT3 expression.
Shen N; Huang X; Li J
Tumour Biol; 2016 Feb; 37(2):1789-96. PubMed ID: 26318305
[TBL] [Abstract][Full Text] [Related]
29. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
Jili S; Eryong L; Lijuan L; Chao Z
Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
[TBL] [Abstract][Full Text] [Related]
30. HSP47 is associated with the prognosis of laryngeal squamous cell carcinoma by inhibiting cell viability and invasion and promoting apoptosis.
Song X; Liao Z; Zhou C; Lin R; Lu J; Cai L; Tan X; Zeng W; Lu X; Zheng W; Chen J; Su Z
Oncol Rep; 2017 Oct; 38(4):2444-2452. PubMed ID: 28849239
[TBL] [Abstract][Full Text] [Related]
31. [The mutation and expression of MUS81 gene in laryngeal squamous cell carcinoma].
Li C; Wang S; Yuan H; Li W; Li Z; Li X; Guo X; Li F
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):560-5. PubMed ID: 18841572
[TBL] [Abstract][Full Text] [Related]
32. IQGAP1 silencing suppresses the malignant characteristics of laryngeal squamous cell carcinoma cells.
Wang X; He C; Li C; Ren B; Deng Q; Gao W; Wang B
Int J Biol Markers; 2018 Jan; 33(1):73-78. PubMed ID: 28708206
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of cyclin D1 by small interfering RNA inhibits cell growth and induces apoptosis of laryngeal squamous cell carcinoma.
Xiao Y; Wang J; Lu J; Liu Y; Wang Y; Gao Y; Jin D
Am J Otolaryngol; 2011; 32(6):541-6. PubMed ID: 21315488
[TBL] [Abstract][Full Text] [Related]
34. Combined p14ARF and antisense EGFR potentiate the efficacy of adenovirus-mediated gene therapy in laryngeal squamous cell carcinoma (LSCC).
Xian J; Lin Y; Liu Y; Gong P; Liu S
DNA Cell Biol; 2007 Feb; 26(2):71-9. PubMed ID: 17328665
[TBL] [Abstract][Full Text] [Related]
35. CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis.
Liu R; Wei H; Gao P; Yu H; Wang K; Fu Z; Ju B; Zhao M; Dong S; Li Z; He Y; Huang Y; Yao Z
Oncotarget; 2017 Jun; 8(24):39021-39032. PubMed ID: 28380460
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of laryngeal cancer cell invasion and growth with lentiviral-vector delivered short hairpin RNA targeting human MMP-9 gene.
Sun Y; Liu M; Yang B; Lu J; Li B
Cancer Invest; 2008 Dec; 26(10):984-9. PubMed ID: 19093256
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA‑503 serves an oncogenic role in laryngeal squamous cell carcinoma via targeting programmed cell death protein 4.
Shuang Y; Zhou X; Li C; Huang Y; Zhang L
Mol Med Rep; 2017 Oct; 16(4):5249-5256. PubMed ID: 28849168
[TBL] [Abstract][Full Text] [Related]
38. Macrocyclic Peptide-Mediated Blockade of the CD47-SIRPα Interaction as a Potential Cancer Immunotherapy.
Hazama D; Yin Y; Murata Y; Matsuda M; Okamoto T; Tanaka D; Terasaka N; Zhao J; Sakamoto M; Kakuchi Y; Saito Y; Kotani T; Nishimura Y; Nakagawa A; Suga H; Matozaki T
Cell Chem Biol; 2020 Sep; 27(9):1181-1191.e7. PubMed ID: 32640189
[TBL] [Abstract][Full Text] [Related]
39. Downregulated Chibby in laryngeal squamous cell carcinoma with increased expression in laryngeal carcinoma Hep-2 cells.
Xu J; Ren G; Zhao DA; Li BA; Cai CF; Zhou Y; Luo XY
Oncol Rep; 2014 Nov; 32(5):1947-56. PubMed ID: 25175341
[TBL] [Abstract][Full Text] [Related]
40. A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer.
Kaur S; Elkahloun AG; Singh SP; Chen QR; Meerzaman DM; Song T; Manu N; Wu W; Mannan P; Garfield SH; Roberts DD
Oncotarget; 2016 Mar; 7(9):10133-52. PubMed ID: 26840086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]